Edition:
United States

DexCom Inc (DXCM.O)

DXCM.O on Nasdaq

79.90USD
21 Feb 2017
Change (% chg)

$-1.99 (-2.43%)
Prev Close
$81.89
Open
$81.07
Day's High
$82.23
Day's Low
$79.68
Volume
881,546
Avg. Vol
1,343,787
52-wk High
$96.38
52-wk Low
$56.52

DXCM.O

Chart for DXCM.O

About

Dexcom, Inc. (Dexcom) is a medical device company. The Company is focused on the design, development and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers for the treatment of people with and without diabetes. Its products include SEVEN PLUS,... (more)

Overall

Beta: 0.48
Market Cap(Mil.): $6,753.48
Shares Outstanding(Mil.): 84.52
Dividend: --
Yield (%): --

Financials

  DXCM.O Industry Sector
P/E (TTM): -- 34.58 29.35
EPS (TTM): -0.68 -- --
ROI: -23.94 12.41 12.97
ROE: -24.92 14.40 14.11

BRIEF-Dexcom says chief financial officer to resign, effective as of April 1

* Dexcom Inc- on Feb 14 Jess Roper, chief financial officer notified Dexcom of his decision to resign, effective as of April 1, 2017 - sec filing

Feb 21 2017

BRIEF-Baillie Gifford & Co reports 7.25% passive stake in Dexcom Inc as of Dec 31, 2016

* Reports 7.25 percent passive stake in Dexcom Inc as of 31 December 2016 - SEC filing Source text (http://bit.ly/2jwYmFB) Further company coverage:

Jan 20 2017

BRIEF-Dexcom reports record preliminary, unaudited revenue for the Q4 and fiscal year 2016

* Dexcom reports record preliminary, unaudited revenue for the fourth quarter and fiscal year 2016 and provides initial 2017 outlook

Jan 10 2017

BRIEF-DexCom Q3 GAAP loss per share $0.22

* Q3 revenue $148.6 million versus I/B/E/S view $146.3 million

Nov 01 2016

More From Around the Web

Competitors

  Price Chg
Roche Holding Ltd. (ROG.S) CHF246.30 -0.20
Roche Holding Ltd. (RO.S) CHF249.90 +0.30
Johnson & Johnson (JNJ.N) $119.52 -0.14
Abbott Laboratories (ABT.N) $45.01 0.00
Medtronic PLC (MDT.N) $79.62 -0.94

Earnings vs. Estimates